BiomX, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

General - Schedule of Fair Value of the Consideration Transferred to APT Shareholders for Acquisition (Details) - APT Shareholders Acquisition [Member] $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($)
Schedule of Fair Value of the Consideration Transferred to APT Shareholders for Acquisition [Line items]
Total	$ 15,851
Common Stock [Member]
Schedule of Fair Value of the Consideration Transferred to APT Shareholders for Acquisition [Line items]
Total	3,041
Redeemable Convertible Preferred Shares [Member]
Schedule of Fair Value of the Consideration Transferred to APT Shareholders for Acquisition [Line items]
Total	12,610
Merger Warrants [Member]
Schedule of Fair Value of the Consideration Transferred to APT Shareholders for Acquisition [Line items]
Total	$ 200